Base Year
Historical Year
Forecast Year
The global prothrombin complex concentrate (PCC) market is expected to grow at a CAGR of about 9% in the forecast period of 2025-2034.
-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America and Europe will be among of the leading regions for prothrombin complex concentrate (PCC) owing to its clinical advantage over fresh frozen plasma. With the advent of Covid-19, there has been an increase in the demand for the PCC. It is because of the noticeable success of plasma-based therapies in the patients. The Asia Pacific region is also expected to rise rapidly with the adoption of Kcentra which was approved by the United States Food and Drug Administration (FDA). The market is also expected to be developed in Latin America and Middle East and Africa with the increased spending on healthcare and improvement of distribution mechanisms.
Prothrombin complex concentrate (PCC) is produced from human plasma and used as a medication comprising blood clotting. It is utilised in the treatment of hemophilia to prevent bleeding. Vitamin K antagonist treatment also accompanies the usage of PCC when acute bleeding occurs. This is listed as one of the safest and most effective medicine in World Health Organisation’s list of essential medicines required in health system.
-market-by-end-use.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
PCC can be divided on the basis of product into:
On the basis of application, PCC can be divided into:
PCC finds its end use in the following:
The regional markets for PCC can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
PCC is expected to have a significant rise because of its clinical advantage against fresh frozen plasma (FPP). PCC needs less volume and infusion time when compared to FFP and is more effective. PCC also does not require blood matching and thawing like FFP. The widespread use of Vitamin K antagonist like warfarin is also expected to drive robust industry growth for PCC. According to FDA, the adult patients undergoing Vitamin K antagonist treatment can have acquired coagulation factor deficiency. In case of acute bleeding, the urgent reversal for such can be done with the indication of PCC, Kcentra. Hemophilic patients are expected to increase in number over upcoming years. Their treatment requires PCC which will further boost the demand. The recent government policies have also worked in the favour for PCC with the relaxation in its usage approval. Government funding has also promoted the use of PCC for bleeding control. COVID-19 has seen rise in plasma related therapies which has rapidly increased PCC demand. Plasma collection centres have been set up by key players to stock up blood demand in PCC.
The report gives a detailed analysis of the following key players in the global prothrombin complex concentrate (PCC) market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global prothrombin complex concentrate (PCC) market is projected to grow at a CAGR of 9% between 2025 and 2034.
The major trends augmenting the market’s growth are the expected rise in the number of haemophilic patients, growth in government initiatives, rising need for plasma related therapies due to COVID-19, increased spending on healthcare, and improvement of distribution mechanisms.
The key trends propelling the market forward are the widespread use of vitamin K antagonists like warfarin and the clinical advantage of PCC over fresh frozen plasma.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific with North America and Europe accounting for the largest share in the market.
PCC can be divided on the basis of product into 3-factor PCC and 4-factor PCC, among others.
On the basis of application, PCC can be divided into acquired coagulation factor deficiency and congenital coagulation factor deficiency, among others.
The end-uses are Hospitals and ambulatory surgical centres, among others.
The major players in the industry are CSL Behring GmbH, Octapharma AG, and Kedrion S.p.A, among others.
Datasheet
USD 2,969
USD 2,499
tax inclusive*
Single User License
One User
USD 5,499
USD 4,699
tax inclusive*
Five User License
Five Users
USD 6,599
USD 5,599
tax inclusive*
Corporate License
Unlimited Users
USD 7,699
USD 6,599
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share